Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

A7-183: Effective topical therapy of recurrent herpes labialis and genitalis

June 7, 1996

Xoma granted U.S. patent for use of BPI

June 7, 1996

Kyowoa Hakko's RP-1551-2: a novel antimicrobial agent

June 7, 1996

Glaxo Wellcome and Otsuka sign grepafloxacin licensing agreement

June 7, 1996

Antiherpes prodrug shows greater activity than aciclovir

May 31, 1996

FDA approves piperacillin sodium/tazobactam sodium for new indication

May 31, 1996

Bayer announces formulation of antibacterial agents

May 31, 1996

Clinical data from Lidakol phase III studies

May 24, 1996

Preliminary phase II results for HNK20

May 24, 1996

RSV inhibitors presented by Wyeth-Ayerst

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...